Literature DB >> 22580622

The effects of siRNA against RPL22 on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells.

Kai Sun1, Hong Xue, Hui Wang, Qiang Wang, Xiang-Rong Zuo, Wei-Ping Xie, Hong Wang.   

Abstract

The aim of this study was to investigate the effects of small interference RNA (siRNA) against ribosomal protein L22 (RPL22) on ET-1-induced proliferation of human pulmonary arterial smooth muscle cells (HPASMCs). HPASMCs were transfected with siRNA against RPL22, incubated in smooth muscle cell culture medium (SMCM) and ET-1. RPL22 gene expression and protein levels of HPASMCs were measured by real-time PCR and western blotting, respectively. PCNA, CCK-8 immunohistochemistry and flow cytometry analysis were used to evaluate HPASMC proliferation. Cyclin D1 (CCND1) expression was also assayed. Following transfection with siRNA against RPL22, RPL22 expression was significantly inhibited in the control and ET-1 groups. HPASMC proliferation was significantly suppressed by transfection with siRNA against RPL22. Moreover, CCND1 was also downregulated by inhibiting RPL22 expression. In conclusion, these data suggest that inhibition of RPL22 expression can suppress HPASMC proliferation and CCND1 expression. The effects of siRNA against RPL22 on HPASMC proliferation are considered to be mediated through inhibition of CCND1 expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580622     DOI: 10.3892/ijmm.2012.992

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

1.  Comparative transcriptomic analysis of skeletal muscle tissue during prenatal stages in Tongcheng and Yorkshire pig using RNA-seq.

Authors:  Huijing Liu; Yu Xi; Guorong Liu; Yuqiang Zhao; Ji Li; Minggang Lei
Journal:  Funct Integr Genomics       Date:  2018-01-10       Impact factor: 3.410

2.  Down-regulation of ribosomal protein L22 in non-small cell lung cancer.

Authors:  Mingxia Yang; Haibo Sun; Hong Wang; Shijiang Zhang; Xiaowei Yu; Lei Zhang
Journal:  Med Oncol       Date:  2013-06-25       Impact factor: 3.064

3.  Frequent mutations in the RPL22 gene and its clinical and functional implications.

Authors:  Akiva P Novetsky; Israel Zighelboim; Dominic M Thompson; Matthew A Powell; David G Mutch; Paul J Goodfellow
Journal:  Gynecol Oncol       Date:  2012-11-02       Impact factor: 5.482

4.  Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.

Authors:  Yusheng Cheng; Min Yu; Jian Xu; Mengyu He; Hong Wang; Hui Kong; Weiping Xie
Journal:  BMC Pulm Med       Date:  2018-08-07       Impact factor: 3.317

5.  The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC Progression via Controlling the TGF-β Signaling Pathway.

Authors:  Kan Ni; Zhiqi Huang; Yichun Zhu; Dandan Xue; Qin Jin; Chunhui Zhang; Changjiang Gu
Journal:  Front Oncol       Date:  2021-06-09       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.